Non‐neuronal TRPA1 encodes mechanical allodynia associated with neurogenic inflammation and partial nerve injury in rats

The pro‐algesic transient receptor potential ankyrin 1 (TRPA1) channel, expressed by a subpopulation of primary sensory neurons, has been implicated in various pain models in mice. However, evidence in rats indicates that TRPA1 conveys nociceptive signals elicited by channel activators, but not those associated with tissue inflammation or nerve injury. Here, in rats, we explored the TRPA1 role in mechanical allodynia associated with stimulation of peptidergic primary sensory neurons (neurogenic inflammation) and moderate (partial sciatic nerve ligation, pSNL) or severe (chronic constriction injury, CCI) sciatic nerve injury.

[1]  Christopher H George,et al.  Planning experiments: Updated guidance on experimental design and analysis and their reporting III , 2022, British journal of pharmacology.

[2]  R. Latorre,et al.  Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice , 2022, Nature Communications.

[3]  Adam J Pawson,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels , 2021, British journal of pharmacology.

[4]  R. Freeman,et al.  Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function , 2021, Pain.

[5]  B. Schmidt,et al.  Peripheral Nerve Resident Macrophages and Schwann Cells Mediate Cancer-Induced Pain , 2021, Cancer Research.

[6]  Christopher H George,et al.  ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020 , 2020, British journal of pharmacology.

[7]  Ulrich Dirnagl,et al.  The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research* , 2020, BMC Veterinary Research.

[8]  P. C. Silveira,et al.  Macrophages and Schwann cell TRPA1 mediate chronic allodynia in a mouse model of complex regional pain syndrome type I , 2020, Brain, Behavior, and Immunity.

[9]  K. Stark,et al.  Behavioral characterization of a CRISPR-generated TRPA1 knockout rat in models of pain, itch, and asthma , 2020, Scientific Reports.

[10]  B. Nilius,et al.  Mammalian transient receptor potential TRPA1 channels: from structure to disease. , 2020, Physiological reviews.

[11]  Zhen Qiao,et al.  Visualizing TRPA1 in the plasma membrane for rapidly screening optical control agonists via a photochromic ligand based fluorescent probe. , 2019, Analytical chemistry.

[12]  P. Geppetti,et al.  Ion Channel Pharmacology for Pain Modulation. , 2019, Handbook of experimental pharmacology.

[13]  N. Bunnett,et al.  Schwann cells expressing nociceptive channel TRPA1 orchestrate ethanol-evoked neuropathic pain in mice. , 2019, The Journal of clinical investigation.

[14]  T. Schnitzer,et al.  CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial. , 2018, Osteoarthritis and cartilage.

[15]  L. Edvinsson,et al.  CGRP as the target of new migraine therapies — successful translation from bench to clinic , 2018, Nature Reviews Neurology.

[16]  Christopher H George,et al.  Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology , 2018, British journal of pharmacology.

[17]  Constance Auvynet,et al.  Stromal cell-derived CCL2 drives neuropathic pain states through myeloid cell infiltration in injured nerve , 2015, Brain, Behavior, and Immunity.

[18]  S. M. Oliveira,et al.  TRPA1 receptor stimulation by hydrogen peroxide is critical to trigger hyperalgesia and inflammation in a model of acute gout. , 2014, Free radical biology & medicine.

[19]  S. Benemei,et al.  The TRPA1 channel in inflammatory and neuropathic pain and migraine. , 2014, Reviews of physiology, biochemistry and pharmacology.

[20]  C. Parada,et al.  The role of transient receptor potential A 1 (TRPA1) in the development and maintenance of carrageenan-induced hyperalgesia , 2013, Neuropharmacology.

[21]  Yanmei Tao.  Isolation and culture of Schwann cells. , 2013, Methods in molecular biology.

[22]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .

[23]  W. S. Denney,et al.  Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974). , 2010, British journal of clinical pharmacology.

[24]  A. Pertovaara,et al.  Attenuation of Mechanical Hypersensitivity by an Antagonist of the TRPA1 Ion Channel in Diabetic Animals , 2009, Anesthesiology.

[25]  David Julius,et al.  Radial stretch reveals distinct populations of mechanosensitive mammalian somatosensory neurons , 2008, Proceedings of the National Academy of Sciences.

[26]  S. Jordt,et al.  TRPA1 is a major oxidant sensor in murine airway sensory neurons. , 2008, The Journal of clinical investigation.

[27]  D. Henze,et al.  HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity , 2008, Molecular pain.

[28]  Michael Zhao,et al.  TRPA1 mediates formalin-induced pain , 2007, Proceedings of the National Academy of Sciences.

[29]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[30]  Peter G. Schultz,et al.  Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines , 2007, Nature.

[31]  A. Patapoutian,et al.  A role of TRPA1 in mechanical hyperalgesia is revealed by pharmacological inhibition , 2007, Molecular pain.

[32]  D. Julius,et al.  TRP channel activation by reversible covalent modification , 2006, Proceedings of the National Academy of Sciences.

[33]  Peter McIntyre,et al.  ANKTM1, a TRP-like Channel Expressed in Nociceptive Neurons, Is Activated by Cold Temperatures , 2003, Cell.

[34]  W. Ma,et al.  Calcitonin gene-related peptide, substance P and protein gene product 9.5 immunoreactive axonal fibers in the rat footpad skin following partial sciatic nerve injuries , 2000, Journal of neurocytology.

[35]  S. Hsu,et al.  of peripheral nerve , 2022 .

[36]  P. Blumberg,et al.  Vanilloid (Capsaicin) receptors and mechanisms. , 1999, Pharmacological reviews.

[37]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[38]  R H LaMotte,et al.  Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. , 1992, The Journal of physiology.

[39]  Ronald Dubner,et al.  A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury , 1990, Pain.

[40]  Gary J. Bennett,et al.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man , 1988, Pain.

[41]  B. Lynn,et al.  Neurogenic inflammation. , 1988, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[42]  W. Dixon,et al.  Efficient analysis of experimental observations. , 1980, Annual review of pharmacology and toxicology.